Clinical biology of the pituitary adenoma
S Melmed, UB Kaiser, MB Lopes, J Bertherat… - Endocrine …, 2022 - academic.oup.com
All endocrine glands are susceptible to neoplastic growth, yet the health consequences of
these neoplasms differ between endocrine tissues. Pituitary neoplasms are highly prevalent …
these neoplasms differ between endocrine tissues. Pituitary neoplasms are highly prevalent …
Multiple endocrine neoplasia type 1: latest insights
ML Brandi, SK Agarwal, ND Perrier, KE Lines… - Endocrine …, 2021 - academic.oup.com
Multiple endocrine neoplasia type 1 (MEN1), a rare tumor syndrome that is inherited in an
autosomal dominant pattern, is continuing to raise great interest for endocrinology …
autosomal dominant pattern, is continuing to raise great interest for endocrinology …
The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism
Importance Primary hyperparathyroidism (pHPT) is a common clinical problem for which the
only definitive management is surgery. Surgical management has evolved considerably …
only definitive management is surgery. Surgical management has evolved considerably …
ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine …
Only advances that occurred from 2011 to 2014 that either strengthen the previous 2011
guidelines [1, 2] or lead to changes or additional guidelines are reviewed here. Advances …
guidelines [1, 2] or lead to changes or additional guidelines are reviewed here. Advances …
Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph… - Jama, 2017 - jamanetwork.com
Importance Guidelines for cancer genetic testing based on family history may miss clinically
actionable genetic changes with established implications for cancer screening or …
actionable genetic changes with established implications for cancer screening or …
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1–G3
F Panzuto, J Ramage, DM Pritchard… - Journal of …, 2023 - Wiley Online Library
The aim of the present guidance paper was to update the previous ENETS guidelines on
well‐differentiated gastric and duodenal neuroendocrine tumours (NETs), providing …
well‐differentiated gastric and duodenal neuroendocrine tumours (NETs), providing …
[HTML][HTML] Somatostatin analogs in clinical practice: a review
M Gomes-Porras, J Cárdenas-Salas… - International journal of …, 2020 - mdpi.com
Somatostatin analogs are an invaluable therapeutic option in the diagnosis and treatment of
somatotropinomas, thyrotropinomas, and functioning and non-functioning …
somatotropinomas, thyrotropinomas, and functioning and non-functioning …
[HTML][HTML] Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical …
ABSTRACT Background Pulmonary carcinoids (PCs) are rare tumors. As there is a paucity
of randomized studies, this expert consensus document represents an initiative by the …
of randomized studies, this expert consensus document represents an initiative by the …
Clinical aspects of multiple endocrine neoplasia type 1
A Al-Salameh, G Cadiot, A Calender… - Nature Reviews …, 2021 - nature.com
Multiple endocrine neoplasia type 1 (MEN1) is a rare syndrome characterized by the co-
occurrence of primary hyperparathyroidism, duodenopancreatic neuroendocrine tumours …
occurrence of primary hyperparathyroidism, duodenopancreatic neuroendocrine tumours …
The North American neuroendocrine tumor society consensus guidelines for surveillance and medical management of pancreatic neuroendocrine tumors
This article is the result of the North American Neuroendocrine Tumor Society consensus
conference on the medical management of pancreatic neuroendocrine tumors from July 19 …
conference on the medical management of pancreatic neuroendocrine tumors from July 19 …